• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衡量和评估人类生命的卫生政策方法:概念和伦理问题。

Health policy approaches to measuring and valuing human life: conceptual and ethical issues.

作者信息

Morrow R H, Bryant J H

机构信息

Department of International Health, School of Hygiene and Public Health, USA.

出版信息

Am J Public Health. 1995 Oct;85(10):1356-60. doi: 10.2105/ajph.85.10.1356.

DOI:10.2105/ajph.85.10.1356
PMID:7573617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1615602/
Abstract

To achieve more cost-effective and equitable use of health resources, improved methods for defining disease burdens and for guiding resource allocations are needed by health care decision makers. Three approaches are discussed that use indicators that combine losses due to disability with losses due to premature mortality as a measure of disease burden. These indicators can also serve as outcome measures for health status in economic analyses. However, their use as tools for measuring and valuing human life raises important questions concerning the measurement of mortality and the multidimensions of morbidity; valuing of life, particularly regarding weighting productivity, dependency, age, and time-preference factors; and conflicts between equity and efficiency that arise in allocation decisions. Further refinement of these tools is needed to (1) incorporate national and local values into weighting; (2) elaborate methods for disaggregating calculations to assess local disease patterns and intervention packages; and (3) develop guidelines for estimating marginal effects and costs of interventions. Of utmost importance are methods that ensure equity while achieving reasonable efficiency.

摘要

为了更具成本效益且公平地利用卫生资源,医疗保健决策者需要改进界定疾病负担和指导资源分配的方法。本文讨论了三种方法,这些方法使用将残疾导致的损失与过早死亡导致的损失相结合的指标作为疾病负担的衡量标准。这些指标还可作为经济分析中健康状况的结果指标。然而,将它们用作衡量和评估人类生命的工具引发了一些重要问题,涉及死亡率的衡量以及发病率的多维度;生命的估值,特别是在权衡生产力、依赖性、年龄和时间偏好因素方面;以及分配决策中出现的公平与效率之间的冲突。需要进一步完善这些工具,以便:(1)将国家和地方价值观纳入权重计算;(2)详细阐述分解计算的方法,以评估地方疾病模式和干预方案;(3)制定估计干预措施边际效应和成本的指南。至关重要的是确保公平同时实现合理效率的方法。

相似文献

1
Health policy approaches to measuring and valuing human life: conceptual and ethical issues.衡量和评估人类生命的卫生政策方法:概念和伦理问题。
Am J Public Health. 1995 Oct;85(10):1356-60. doi: 10.2105/ajph.85.10.1356.
2
Justice and outcomes research: the ethical limits.公正与结果研究:伦理界限
J Clin Ethics. 1993 Fall;4(3):258-61.
3
Accessibility, ethics and equity in health care.医疗保健中的可及性、伦理与公平性。
Soc Sci Med. 1993 Jun;36(12):iii-vii.
4
Quality-adjusted life-years. Ethical implications for physicians and policymakers.质量调整生命年。对医生和政策制定者的伦理影响。
JAMA. 1990 Jun 6;263(21):2917-21. doi: 10.1001/jama.263.21.2917.
5
An epidemiological approach towards measuring the trade-off between equity and efficiency in health policy.一种衡量卫生政策中公平与效率之间权衡取舍的流行病学方法。
Health Policy. 1996 Mar;35(3):205-16. doi: 10.1016/0168-8510(95)00783-0.
6
Economics, QALYs and medical ethics: a practical agenda?经济学、质量调整生命年与医学伦理学:一项切实可行的议程?
Health Care Anal. 1995 Aug;3(3):229-32. doi: 10.1007/BF02197673.
7
Clinical practice guidelines as tools of public policy: conflicts of purpose, issues of autonomy, and justice.作为公共政策工具的临床实践指南:目的冲突、自主性问题与正义问题
J Clin Ethics. 1994 Winter;5(4):303-9.
8
Research on "big ticket" items: ethical implications for equitable access.关于“大额项目”的研究:公平获取的伦理考量
J Law Med Ethics. 1994 Summer;22(2):148-51. doi: 10.1111/j.1748-720x.1994.tb01288.x.
9
Vertical equity: weighting outcomes? or establishing procedures?纵向公平:对结果进行加权?还是确立程序?
Health Policy. 1997 Jan;39(1):79-87. doi: 10.1016/s0168-8510(96)00851-2.
10
The morality of efficiency in health care--some uncomfortable implications.医疗保健中的效率道德——一些令人不安的影响。
Health Econ. 1992 Apr;1(1):7-18. doi: 10.1002/hec.4730010105.

引用本文的文献

1
Musculoskeletal health: an ecological study assessing disease burden and research funding.肌肉骨骼健康:一项评估疾病负担和研究资金的生态学研究。
Lancet Reg Health Am. 2024 Jan 8;29:100661. doi: 10.1016/j.lana.2023.100661. eCollection 2024 Jan.
2
Reframing Optimal Control Problems for Infectious Disease Management in Low-Income Countries.重新构建低收入国家传染病管理的最优控制问题。
Bull Math Biol. 2023 Mar 12;85(4):31. doi: 10.1007/s11538-023-01137-4.
3
The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.美国多发性硬化症的经济负担:直接和间接成本的估计。
Neurology. 2022 May 3;98(18):e1810-e1817. doi: 10.1212/WNL.0000000000200150. Epub 2022 Apr 13.
4
Reflections on key methodological decisions in national burden of disease assessments.关于国家疾病负担评估中关键方法学决策的思考
Arch Public Health. 2020 Dec 31;78(1):137. doi: 10.1186/s13690-020-00519-7.
5
Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa.评估南非商业保险个体共病的地理分布。
BMC Public Health. 2020 Nov 16;20(1):1709. doi: 10.1186/s12889-020-09771-6.
6
Current and projected future economic burden of Parkinson's disease in the U.S.美国帕金森病当前及预计未来的经济负担
NPJ Parkinsons Dis. 2020 Jul 9;6:15. doi: 10.1038/s41531-020-0117-1. eCollection 2020.
7
Direct comparison of cervical and high thoracic spinal cord injury reveals distinct autonomic and cardiovascular consequences.颈椎和高位胸椎脊髓损伤的直接比较揭示了不同的自主神经和心血管后果。
J Appl Physiol (1985). 2020 Mar 1;128(3):554-564. doi: 10.1152/japplphysiol.00721.2019. Epub 2020 Jan 30.
8
Measuring the health of populations: explaining composite indicators.衡量人群健康状况:解读综合指标。
J Public Health Res. 2012 Dec 28;1(3):222-8. doi: 10.4081/jphr.2012.e35.
9
NIH disease funding levels and burden of disease.NIH 疾病资助水平与疾病负担。
PLoS One. 2011 Feb 24;6(2):e16837. doi: 10.1371/journal.pone.0016837.
10
Access to high cost medicines in Australia: ethical perspectives.澳大利亚高价药品的获取:伦理视角
Aust New Zealand Health Policy. 2008 May 19;5:4. doi: 10.1186/1743-8462-5-4.

本文引用的文献

1
Measurement of health state utilities for economic appraisal.用于经济评估的健康状态效用测量。
J Health Econ. 1986 Mar;5(1):1-30. doi: 10.1016/0167-6296(86)90020-2.
2
The quality of QALYs (quality-adjusted-life-years): do QALYs measure what they at least intend to measure?质量调整生命年(QALYs)的质量:QALYs是否衡量了它们至少想要衡量的东西?
Health Policy. 1989 Oct;13(1):81-3. doi: 10.1016/0168-8510(89)90112-7.
3
Should basic care get priority? Doubts about rationing the Oregon way.基本医疗应该优先保障吗?对俄勒冈州医疗资源分配方式的质疑。
Kennedy Inst Ethics J. 1991 Sep;1(3):187-206. doi: 10.1353/ken.0.0173.
4
Health as a human right: an epidemiologist's perspective on the public health.健康作为一项人权:一位流行病学家对公共卫生的看法。
Am J Public Health. 1993 Mar;83(3):418-26. doi: 10.2105/ajph.83.3.418.
5
Quantifying disability: data, methods and results.量化残疾:数据、方法与结果。
Bull World Health Organ. 1994;72(3):481-94.
6
Quantifying the burden of disease: the technical basis for disability-adjusted life years.疾病负担的量化:伤残调整生命年的技术基础。
Bull World Health Organ. 1994;72(3):429-45.
7
The application of a quantitative approach to the assessment of the relative importance of vector and soil transmitted diseases in Ghana.定量方法在评估加纳病媒传播疾病和土壤传播疾病相对重要性中的应用。
Soc Sci Med. 1984;19(10):1039-49. doi: 10.1016/0277-9536(84)90306-x.
8
Evaluating healthy days of life gained from health projects.评估从健康项目中获得的健康生活天数。
Soc Sci Med. 1987;24(10):833-41. doi: 10.1016/0277-9536(87)90184-5.
9
The use of QALYs in health care decision making.质量调整生命年在医疗保健决策中的应用。
Soc Sci Med. 1989;28(4):299-308. doi: 10.1016/0277-9536(89)90030-0.
10
Utilities and quality-adjusted life years.效用与质量调整生命年。
Int J Technol Assess Health Care. 1989;5(4):559-75. doi: 10.1017/s0266462300008461.